Fernando A. Happa

JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production

Timothy P. LaBranche, Michael I. Jesson, Chad Storer et al. · Arthritis & Rheumatism · 2012 · 136 citations

Medicine, Immunology, Pharmacology +17

Critical role for apoptosis signal-regulating kinase 1 in the development of inflammatory K/BxN serum-induced arthritis

Stephen J. Mnich, Patrick M. Blanner, Liangbiao George Hu et al. · International Immunopharmacology · 2010 · 36 citations

Life Sciences, Cell Biology, Immunology +12

CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain

Luz Cortes-Burgos, Ben S. Zweifel, Steven L. Settle et al. · European Journal of Pharmacology · 2009 · 36 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Characterization of the KRN Cell Transfer Model of Rheumatoid Arthritis (KRN-CTM), a Chronic Yet Synchronized Version of the K/BxN Mouse

Timothy P. LaBranche, Cynthia L. Hickman‐Brecks, Debra M. Meyer et al. · American Journal Of Pathology · 2010 · 33 citations · Full text

Life Sciences, Cell Biology, Immunology +11

Acute Lymphoid and Gastrointestinal Toxicity Induced by Selective p38α Map Kinase and Map Kinase–Activated Protein Kinase-2 (MK2) Inhibitors in the Dog

Dale L. Morris, Shawn P. O’Neil, Rajesh Devraj et al. · Toxicologic Pathology · 2010 · 18 citations

Veterinary Medicine, Toxicology, Veterinary Toxicology +17